製品番号: HY-B0158

シチジン

(別名: Cytidine; Cytosine β-D-riboside; Cytosine-1-β-D-ribofuranoside)

8 Cited Publications

カスタマーレビュー

Based on 8 publication(s) in Google Scholar

Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度: 99.97%
CAS 番号: 65-46-3
分子式: C₉H₁₃N₃O₅
分子量:243.22

保管条件:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year

Cytidine 構造式

CAS 番号: 65-46-3

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性
- 製品説明
- IC₅₀ & Target
- Cellular Effect
- 体内実験
化学情報
Publications (8)
溶剤 & 溶解度
- 体外
- 体内
純度とドキュメンテーション
参考文献
Help & FAQs
関連分類
Bioz

生物活性

製品説明

IC₅₀ & Target

Microbial Metabolite

Human Endogenous Metabolite

Endogenous Metabolite アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
HOS-TE85	IC₅₀	2.6 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Osteosarcoma MNNG-HOS cell line Inhibitory effect tested in vitro for the growth of Osteosarcoma MNNG-HOS cell line	[PMID: 1895307]
KHOS-321H	IC₅₀	0.27 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Osteosarcoma KHOS-321H cell line Inhibitory effect tested in vitro for the growth of Osteosarcoma KHOS-321H cell line	[PMID: 1895307]
MKN-28	IC₅₀	4.5 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Stomach adenocarcinoma MKN- 28 cell line Inhibitory effect tested in vitro for the growth of Stomach adenocarcinoma MKN- 28 cell line	[PMID: 1895307]
NUGC-4	IC₅₀	>100 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Stomach adenocarcinoma NUGC-4 cell line Inhibitory effect tested in vitro for the growth of Stomach adenocarcinoma NUGC-4 cell line	[PMID: 1895307]
OST	IC₅₀	>100 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Osteosarcoma OST cell line Inhibitory effect tested in vitro for the growth of Osteosarcoma OST cell line	[PMID: 1895307]
PC-13	IC₅₀	>100 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Lung adenocarcinoma PC-13 cell line Inhibitory effect tested in vitro for the growth of Lung adenocarcinoma PC-13 cell line	[PMID: 1895307]
PC-3	IC₅₀	>100 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Lung adenocarcinoma PC-3 cell line Inhibitory effect tested in vitro for the growth of Lung adenocarcinoma PC-3 cell line	[PMID: 1895307]
PC-8	IC₅₀	0.28 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Lung adenocarcinoma PC-8 cell line Inhibitory effect tested in vitro for the growth of Lung adenocarcinoma PC-8 cell line	[PMID: 1895307]
PC-9	IC₅₀	1.6 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Lung adenocarcinoma PC-9 cell line Inhibitory effect tested in vitro for the growth of Lung adenocarcinoma PC-9 cell line	[PMID: 1895307]
QG-56	IC₅₀	>100 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Lung squamous-cell carcinoma QG-56 cell line Inhibitory effect tested in vitro for the growth of Lung squamous-cell carcinoma QG-56 cell line	[PMID: 1895307]
SK-ES1	IC₅₀	0.09 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Osteosarcoma SK-ES-1 cell line Inhibitory effect tested in vitro for the growth of Osteosarcoma SK-ES-1 cell line	[PMID: 1895307]
ST-KM-1	IC₅₀	>100 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of Stomach adenocarcinoma ST-KM cell line Inhibitory effect tested in vitro for the growth of Stomach adenocarcinoma ST-KM cell line	[PMID: 1895307]
SW480	IC₅₀	>100 μg/mL Compound: Cytidine	Inhibitory effect tested in vitro for the growth of colon adenocarcinoma SW-480 cell line Inhibitory effect tested in vitro for the growth of colon adenocarcinoma SW-480 cell line	[PMID: 1895307]

体内実験

Cytidine decreases glutamate/glutamine levels and induces earlier improvement of depressive symptoms^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

化学情報

CAS 番号 65-46-3
性状 Solid
分子量 243.22
分子式 C₉H₁₃N₃O₅
Color White to off-white
SMILES

O[C@H]1[C@@H](O)[C@H](N2C(N=C(N)C=C2)=O)O[C@@H]1CO
別名

Cytidine; Cytosine β-D-riboside; Cytosine-1-β-D-ribofuranoside
Structure Classification
- Others
Initial Source
- Plants
- other families
- Endogenous metabolite
- Human Gut Microbiota Metabolites
- Animals
- Microorganisms
Widespread
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	2 years
	-20°C	1 year

Publications (8)

All RT-PCRCell Imaging/StainingCell Proliferation/Viability AssayCell Migration/Invasion Assay

Sort by:

Journal Impact Factor

Imeta

2026 Feb 24.

Cytidine purchased from MedChemExpress. Usage Cited in: Imeta. 2026 Feb 24.

Cytidine (15 μM; 12 h) significantly increased the transcription of the viral gene 2A in EV-D68-infected RD cells.
Nat Mach Intell

2025 May.
Information Processing in Agriculture

2026 Mar 3.

Cytidine purchased from MedChemExpress. Usage Cited in: Information Processing in Agriculture. 2026 Mar 3.

Cytidine (200 μM; 24 h) significantly suppressed CYP19A1 expression in female gonadal cells.
Molecules

Untargeted Metabolomics Using UHPLC-HRMS Reveals Metabolic Changes of Fresh-Cut Potato during Browning Process. [Abstract]

2023 Apr 11;28(8):3375. PMID: 37110608
Mol Med Rep

Causal association between metabolites and upper gastrointestinal tumors: A Mendelian randomization study. [Abstract]

2024 Dec;30(6):212. PMID: 39370813
J Mol Med (Berl)

Combination of PARP inhibitor and temozolomide to suppress chordoma progression. [Abstract]

2019 Aug;97(8):1183-1193. PMID: 31201471
J Pharm Biomed Anal

A novel UHPLC-MS/MS approach for simultaneous quantification of pyrimidine metabolites in human biofluids. [Abstract]

2025 Jun 17:265:117026. PMID: 40544701

Cytidine purchased from MedChemExpress. Usage Cited in: J Pharm Biomed Anal. 2025 Jun 17:265:117026. [Abstract]

Cytidine (50-100 µM; 72 h) inhibited the proliferation of both EC (KYSE150 cell) and GC (HGC27 cell) cell lines.

Cytidine purchased from MedChemExpress. Usage Cited in: J Pharm Biomed Anal. 2025 Jun 17:265:117026. [Abstract]

Cytidine (50-100 µM; 72 h) inhibited the migration of both EC (KYSE150 cell) and GC (HGC27 cell) cell lines.
University of Hawaii

2023 May.

Cytidine purchased from MedChemExpress. Usage Cited in: University of Hawaii. 2023 May.

Cytidine (205-410 µM; 4 d) significantly mitigated the negative effects of NHC on EBs.

溶剤 & 溶解度

体外:

H₂O : ≥ 50 mg/mL (205.58 mM)

DMSO : 50 mg/mL (205.58 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

* "≥" means soluble, but saturation unknown.

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

4.1115 mL

20.5575 mL

41.1150 mL

5 mM

0.8223 mL

4.1115 mL

8.2230 mL

10 mM

0.4112 mL

2.0558 mL

4.1115 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (10.28 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 2.5 mg/mL (10.28 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 2.5 mg/mL (10.28 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

Working Solution

For the following dissolution methods, please prepare the working solution directly:

It is recommended to prepare fresh solutions and use them promptly within a short period of time.

The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: PBS

Solubility: 100 mg/mL (411.15 mM); Clear solution; Need ultrasonic

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Working solution concentration: 0.22 mg/mL

This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact

MedChemExpress (MCE) .

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (277 KB)
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Jonas DA, et al. Safety considerations of DNA in food. Ann Nutr Metab. 2001;45(6):235-54. [Content Brief]

[2]. Wurtman RJ, et al. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol. 2000 Oct 1;60(7):989-92. [Content Brief]

[3]. Machado-Vieira R, et, al. New therapeutic targets for mood disorders. ScientificWorldJournal. 2010 Apr 13;10:713-26. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
H₂O / DMSO	1 mM	4.1115 mL	20.5575 mL	41.1150 mL	102.7876 mL
	5 mM	0.8223 mL	4.1115 mL	8.2230 mL	20.5575 mL
	10 mM	0.4112 mL	2.0558 mL	4.1115 mL	10.2788 mL
	15 mM	0.2741 mL	1.3705 mL	2.7410 mL	6.8525 mL
	20 mM	0.2056 mL	1.0279 mL	2.0558 mL	5.1394 mL
	25 mM	0.1645 mL	0.8223 mL	1.6446 mL	4.1115 mL
	30 mM	0.1371 mL	0.6853 mL	1.3705 mL	3.4263 mL
	40 mM	0.1028 mL	0.5139 mL	1.0279 mL	2.5697 mL
	50 mM	0.0822 mL	0.4112 mL	0.8223 mL	2.0558 mL
	60 mM	0.0685 mL	0.3426 mL	0.6853 mL	1.7131 mL
	80 mM	0.0514 mL	0.2570 mL	0.5139 mL	1.2848 mL
	100 mM	0.0411 mL	0.2056 mL	0.4112 mL	1.0279 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Keywords

Cytidine

8 Cited Publications

100 mg お問い合わせ

Subscribe to the

MedChemExpress

Newsletter

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

シチジン

Cell Cycle/DNA Damage Compound Library

Metabolism/Protease Compound Library

Natural Product Library

FDA-Approved Drug Library

Human Endogenous Metabolite Compound Library

Anti-Aging Compound Library

Drug Repurposing Compound Library

Reprogramming Compound Library

Glycoside Compound Library

Nucleotide Compound Library

Anti-COVID-19 Compound Library

NMPA-Approved Drug Library

Traditional Chinese Medicine Active Compound Library

FDA Approved & Pharmacopeial Drug Library

Anti-Lung Cancer Compound Library

Gut Microbial Metabolite Library

Anti-Blood Cancer Compound Library

Anti-Cancer Metabolism Compound Library

Microbial Metabolite Library

Food-Sourced Compound Library

Plant-Sourced Natural Product Library

EMA-Approved Drug Library

Human Metabolite Library

Off-patent Drug Library

Animal-Sourced Natural Product Library

FDA-Approved Traditional Chinese Medicine Active Compound Library

Anti-Hematopathy Compound Library

Multi-Target Compound Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Natural Product Library Plus

Drug Repurposing Compound Library Plus

FDA-Approved Drug Library Plus

FDA-Approved Drug Library Mini

Natural Product and Natural Product-Like Compound Library

Bioactive Compound Library

Tibetan Medicine Compound Library

RO5 Drug-like Natural Product Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Mass Spectrometry Human Endogenous Metabolite Library

Ancient Chinese Classical Formulas Traditional Chinese Medicine Active Compound Library

Mass Spectrometry Human Metabolite Library

Mouse Metabolite Compound Library

Antitussive and Antiasthmatic Traditional Chinese Medicine Active Compound Library

Diarrhea-Related Traditional Chinese Medicine Active Compound Library

Nucleotide Metabolite Compound Library

Mongolian Medicine Compound Library

Fungal-Sourced Compound Library

Mass Spectrometry Natural Product Library

MedChemExpress（MCE）の使用を引用している文献 Cytidine

Endogenous Metabolite アイソフォーム固有の製品をすべて表示

生物活性

化学情報

Publications (8)

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

Cytidine 関連分類

HY-B0158 関連分類